Has Thomas Crawford, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,056 in general payments to Thomas Crawford, MD across 47 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Crawford, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Crawford, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Crawford, MD

Clinical Cardiac Electrophysiology · Ann Arbor, MINPI 1053430496

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $13,222 of the $21,056 with a category attached, or 62.8%. Kestra Medical Technology Services, Inc. accounts for 63.3% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $13,797, more than ten times the $120 reported in 2019.

$21,056in general payments, 2019–2025

Across 47 payments — averaging $448.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Kestra Medical Technology Services, Inc.$13K
Abbott$4K
Medtronic$2K
Atricure, Inc.$1K
Boston Scientific$297
Philips North America LLC$252
plus $184 from 3 others

$276,600in research payments, 2019–2025

Across 55 payments — averaging $5029.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$223K
Abbott$54K

What the payments were for

Consulting fees$13,22263%
Travel & lodging$5,84828%
Food & beverage$1,9719%
Education$140%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Kestra Medical Technology Services, Inc.	4	$13,324
Abbott	19	$3,769
Medtronic(2 entities)	9	$1,762
Atricure, Inc.	6	$1,471
Boston Scientific	3	$297
Philips North America LLC	3	$252
Impulse Dynamics (USA) Inc.	1	$154
Cardiva Medical, Inc.	1	$15
Biotronik Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Assure WCD$13,324
AVEIR$3,347
EVERA MRI XT DR SURESCAN$1,374
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,256
OPTIMIZER$308
(9520) IGT Devices Undivided$235
COBALT DR MRI SURESCAN$155

How this compares

$21,056 in reported general payments places this provider in the 55th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

See all clinical cardiac electrophysiology providers in Michigan →

Medicare billing

Part B allowed, 2024

$84,863

Medicare patients

434

Services billed

733

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	179	$220,433
XareltoRivaroxaban	46	$49,214
Dofetilide	55	$9,668
Flecainide Acetate	49	$3,118
Amiodarone Hcl	44	$2,906
Mexiletine Hcl	16	$2,616
Metoprolol Succinate	85	$2,110
SotalolSotalol Hcl	27	$805
Diltiazem 24hr Er (Cd)Diltiazem Hcl	15	$293
Metoprolol Tartrate	15	$230
Warfarin Sodium	12	$159

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Ann Arbor

Jackson LiangAnn Arbor$229K
Ryan CunnaneAnn Arbor$218K
Daniel AlyeshAnn Arbor$97K
Kelly ArpsAnn Arbor$96K
Emma HegwoodAnn Arbor$74K
Muazzum ShahAnn Arbor$57K
Frank PelosiAnn Arbor$51K
Hamid GhanbariAnn Arbor$47K
Boldizsar KovacsAnn Arbor$43K
Amrish DeshmukhAnn Arbor$21K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →